Navigation Links
Smokers More Likely to Develop Dementia
Date:9/4/2007

Tobacco users had a 50% higher risk for Alzheimer's, Dutch study finds

TUESDAY, Sept. 4 (HealthDay News) -- Current smokers are 50 percent more likely to develop Alzheimer's disease or dementia than people who don't smoke or who gave up smoking, a Dutch report says.

Researchers announced these results after analyzing seven years of data from almost 7,000 people over age 55.

Over the course of the study, 706 people developed dementia. People who were smokers during the study were 50 percent more likely to develop dementia than people who had never smoked or were former smokers, according to the researchers, who published their findings in the Sept. 4 issue of Neurology.

"Smoking increases the risk of cerebrovascular disease, which is also tied to dementia," study author Dr. Monique Breteler, of Erasmus Medical Center in Rotterdam, the Netherlands, said in a prepared statement. "Another mechanism could be through oxidative stress, which can damage cells in the blood vessels and lead to hardening of the arteries. Smokers experience greater oxidative stress than nonsmokers, and increased oxidative stress is also seen in Alzheimer's disease."

Oxidative stress occurs when there are too many waste products from chemical reactions in the body. Dietary antioxidants can fight those waste products, known as free radicals, but Breteler said that smokers are also known to have fewer antioxidants in their diets than nonsmokers.

The researchers also studied the way that smoking affects the risk of Alzheimer's disease for people who carry the related gene. They found that smoking did not increase the risk for those with the gene for Alzheimer's disease, but it did increase the risk for people without the gene. Current smokers without the gene were 70 percent more likely to develop Alzheimer's disease than nonsmokers or former smokers without the gene.

More information

To learn more about smoking cessation, visit the American Cancer Society Guide to Quitting Smoking.



-- Madeline Vann



SOURCE: American Academy of Neurology, news release, Sept. 3, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Half of worlds children are passive smokers - damning disclosure from WHO
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Poor diet among smokers
4. Pregnant smokers could harm their child
5. Creating A Greater Awareness Among Smokers
6. B-Carotene Increases Oral Cancer Risk In Smokers
7. Smokers Cloud Has A Silver Lining?
8. Smokers children likely to develop caries
9. Drinkers and smokers are at risk
10. A new method to help smokers quit
11. Poor diet among smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: